Indication
Treatment of diabetes mellitus.
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Loading your page…
Loading your page…
Diabetes Mellitus
Marketing Authorisation Holder: Novo Nordisk A/S
EMA Authorisation: 07/10/2002
INN: insulin human (rDNA)
AI Drug & Interaction Analysis
Free account required
Ask Osler about Actraphane: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.